Home The Word Brain My Amedeo FAQ Privacy About   

2049 Chinese

The 20K Word Road to Mandarin Proficiency

By B. S. Kamps et al.

  Prostate Cancer

  Free Subscription

Articles published in Urol Int

Retrieve available abstracts of 61 articles:
HTML format

Single Articles

    March 2024
  1. SIMSEK A, Celen S, Duran MB, Kucuker K, et al
    Urol Int. 2024 Mar 13. doi: 10.1159/000538061.
    PubMed     Abstract available

  2. HU S, Xiong X, Qiu S, Li J, et al
    Comparing efficacies of different exercises on androgen deprivation therapy adverse effects in prostate cancer patients: a network meta-analysis.
    Urol Int. 2024 Mar 2. doi: 10.1159/000538114.
    PubMed     Abstract available

    January 2024
  3. RIEDEL A, Michael M, Grunberg J, Mehralivand S, et al
    The role of multiparametric MRI (mpMRI) in the prediction of adverse prostate cancer pathology in radical prostatectomy specimen.
    Urol Int. 2024 Jan 19. doi: 10.1159/000536256.
    PubMed     Abstract available

  4. WU S, Feldman AS, Lin SX, Kim MM, et al
    Estimated Prostate Volume by Semiautomatic Segmentation of MRI Is More Accurately Correlated with Radical Prostatectomy Specimen Weight than the Volume Calculated by Ellipsoid Formula.
    Urol Int. 2024;108:35-41.
    PubMed     Abstract available

    November 2023
  5. CANKAYA S, Caylan AE, Aydin F, Ucar M, et al
    Correlation between prostate cancer positive cores and 68Ga-PSMA distribution in prostate gland.
    Urol Int. 2023 Nov 28. doi: 10.1159/000535466.
    PubMed     Abstract available

  6. CUI Y, Zhao J, Sun Y
    The Value of the Prostate Health Index and Derived Indexes in the Diagnosis of Prostate Cancer with PI-RADS-3 Lesions.
    Urol Int. 2023 Nov 27:1-6. doi: 10.1159/000534597.
    PubMed     Abstract available

  7. SENEL S, Koudonas A, Uzun E, Ceviz K, et al
    The Value of Prostate-Specific Antigen Density in Combination with Lesion Diameter for the Accuracy of Prostate Cancer Prediction in Prostate Imaging-Reporting and Data System 3 Prostate Lesions.
    Urol Int. 2023 Nov 20:1-6. doi: 10.1159/000534805.
    PubMed     Abstract available

  8. SIKIC D, Fiebig C, Wullich B, Wolff I, et al
    Patient Benefits of Radical Prostatectomy in Certified Prostate Cancer Centers: Comparative Results from the Multicenter IMPROVE Study.
    Urol Int. 2023 Nov 6:1-10. doi: 10.1159/000534486.
    PubMed     Abstract available

    June 2023
  9. LONG J, Liu Z, Liang S, Chen B, et al
    Cruciferous Vegetable Intake and Risk of Prostate Cancer: A Systematic Review and Meta-Analysis.
    Urol Int. 2023 Jun 21:1-11. doi: 10.1159/000530435.
    PubMed     Abstract available

  10. FERNANDEZ-ANGUITA PJ, Ventosa-Puig M, Diaz de Mera-Sanchez Migallon I, Legido-Gomez O, et al
    Value of Prostate-Specific Antigen Kinetics in Patients with Low-Risk Prostate Cancer under Active Surveillance.
    Urol Int. 2023 Jun 16:1-7. doi: 10.1159/000530963.
    PubMed     Abstract available

    April 2023
  11. YOO S, Lee KH, Jamrasi P, Cho MC, et al
    Effects of Exercise on Physical Function and Quality of Life in Prostate Cancer Patients Receiving Androgen Deprivation Therapy: High-Intensity Interval Training versus Moderate-Intensity Continuous Training.
    Urol Int. 2023 Apr 25:1-8. doi: 10.1159/000527839.
    PubMed     Abstract available

  12. MEYER L, Bohlscheid A, Lemmer O, van de Plas J, et al
    MR-Guided Transurethral Ultrasound Ablation of Prostate Cancer: Initial Experience of Monitoring Tumor Response by Dynamic Apparent Diffusion Coefficient Measurements at 3.0 T.
    Urol Int. 2023 Apr 18:1-9. doi: 10.1159/000529873.
    PubMed     Abstract available

  13. BAHLBURG H, Tully K, Hoffmann V, Hanske J, et al
    Avoiding Prostate Biopsies in Patients at Low Risk for Prostate Cancer: A Prospective Evaluation of a PSA-Density-Based Safety Net.
    Urol Int. 2023 Apr 14:1-6. doi: 10.1159/000529946.
    PubMed     Abstract available

  14. QIAN L, Wang Y, Xiong Y, Ren H, et al
    LINC01002 Targets miR-650/FLNA Pathway to Suppress Prostate Cancer Progression.
    Urol Int. 2023 Apr 11:1-13. doi: 10.1159/000529947.
    PubMed     Abstract available

    March 2023
  15. WANG Y, Chen X, Liu K, Liu R, et al
    Predictive Factors for Gleason Score Upgrading in Patients with Prostate Cancer after Radical Prostatectomy: A Systematic Review and Meta-Analysis.
    Urol Int. 2023 Mar 29:1-20. doi: 10.1159/000528873.
    PubMed     Abstract available

    February 2023
  16. LOPCI E, Lazzeri M, Colombo P, Casale P, et al
    Diagnostic Performance and Clinical Impact of PSMA PET/CT versus mpMRI in Patients with a High Suspicion of Prostate Cancer and Previously Negative Biopsy: A Prospective Trial (PROSPET-BX).
    Urol Int. 2023 Feb 1:1-7. doi: 10.1159/000528720.
    PubMed     Abstract available

    January 2023
  17. FLEGAR L, Thoduka SG, Mahnken AH, Figiel J, et al
    Focal Therapy for Renal Cancer: Comparative Trends in the USA and Germany from 2006 to 2020 and Analysis of the German Health Care Landscape.
    Urol Int. 2023;107:396-405.
    PubMed     Abstract available

  18. SHEN C, Zhang DL, Cheng XL, Zhang WC, et al
    Urological Tumor: A Narrative Review of Tertiary Lymphatic Structures.
    Urol Int. 2023;107:841-847.
    PubMed     Abstract available

  19. SCARCIA M, Moretto S, Zazzara M, Alba S, et al
    Robot-Assisted Extraperitoneal Radical Prostatectomy for Giant Multilocular Prostatic Cystadenoma: A Case Report and Literature Review.
    Urol Int. 2023;107.
    PubMed     Abstract available

  20. STOLZENBACH LF, Fankhauser CD, Mattei A, Wurnschimmel C, et al
    Solitary Fibrous Tumor of the Prostate Treated with Frozen-Section Supported Robot-Assisted Nerve-Sparing Radical Prostatectomy.
    Urol Int. 2023;107.
    PubMed     Abstract available

    November 2022
  21. SOTOMAYOR PC, Aguilar JC, Mujica K, Zuniga A, et al
    Active Surveillance in Prostate Cancer: Current and Potentially Emerging Biomarkers for Patient Selection Criteria.
    Urol Int. 2022 Nov 7:1-13. doi: 10.1159/000527151.
    PubMed     Abstract available

    October 2022
  22. BORKOWETZ A, Linxweiler J, Fussek S, Wullich B, et al
    The Role of PSMA PET Imaging in Prostate Cancer Theranostics: A Nationwide Survey.
    Urol Int. 2022 Oct 4:1-10. doi: 10.1159/000526598.
    PubMed     Abstract available

    March 2022
  23. WU J, Wei Y, Li T, Lin L, et al
    DNA Methylation-Mediated Lowly Expressed AOX1 Promotes Cell Migration and Invasion of Prostate Cancer.
    Urol Int. 2022 Mar 30:1-9. doi: 10.1159/000522634.
    PubMed     Abstract available

  24. MAKINO K, Sato Y, Takenaka R, Yamashita H, et al
    Cumulative Incidence and Clinical Risk Factors of Radiation Cystitis after Radiotherapy for Prostate Cancer.
    Urol Int. 2022 Mar 15:1-7. doi: 10.1159/000521723.
    PubMed     Abstract available

  25. HIGASHIYAMA S, Yoshida A, Kawabe J
    Predicting the Prognosis of Prostate Cancer Bone Metastasis Using the Bone Scan Index and Hot Spots Calculated Using VSBONE Bone Scan Index from Tc-99m-Hydroxymethylene Diphosphonate Bone Scintigraphy.
    Urol Int. 2022 Mar 4:1-7. doi: 10.1159/000522046.
    PubMed     Abstract available

    February 2022
  26. JIN C, Bian Z, Mo F, Zhu C, et al
    Establishment and Validation of Coagulation Factor-Based Nomogram for Predicting the Recurrence-Free Survival of Prostate Cancer.
    Urol Int. 2022 Feb 18:1-9. doi: 10.1159/000519329.
    PubMed     Abstract available

  27. SOKMEN BK, Sokmen D, Comez YI, Eksi M, et al
    Prediction of Prostate Cancer Aggressiveness Using a Novel Multiparametric Magnetic Resonance Imaging Parameter: Tumor Heterogeneity Index.
    Urol Int. 2022 Feb 11:1-8. doi: 10.1159/000521606.
    PubMed     Abstract available

  28. BORKOWETZ A, Blana A, Bohmer D, Cash H, et al
    German S3 Evidence-Based Guidelines on Focal Therapy in Localized Prostate Cancer: The First Evidence-Based Guidelines on Focal Therapy.
    Urol Int. 2022 Feb 10:1-9. doi: 10.1159/000521882.
    PubMed     Abstract available

  29. CAFUTA B, Distler FA, Wagner A, Pahernik S, et al
    Salvage Radiotherapy for Recurrent Prostate Cancer after High-Intensity Focused Ultrasound Therapy: Quality of Life and Functional Outcome.
    Urol Int. 2022 Feb 1:1-6. doi: 10.1159/000521660.
    PubMed     Abstract available

    January 2022
  30. PORCARO AB, Panunzio A, Tafuri A, Cerrato C, et al
    The Influence of Endogenous Testosterone Density on Unfavorable Disease and Tumor Load at Final Pathology in Intermediate-Risk Prostate Cancer: Results in 338 Patients Treated with Radical Prostatectomy and Extended Pelvic Lymph Node Dissection.
    Urol Int. 2022 Jan 26:1-12. doi: 10.1159/000521260.
    PubMed     Abstract available

  31. HARLAND N, Russo GI, Kaufmann S, Amend B, et al
    Robotic Transrectal Computed Tomographic Ultrasound with Artificial Neural Network Analysis: First Validation and Comparison with MRI-Guided Biopsies and Radical Prostatectomy.
    Urol Int. 2022;106:90-96.
    PubMed     Abstract available

  32. WETTERAUER C, Federer-Gsponer JR, Leboutte FDJP, Mona R, et al
    Indication for Active Surveillance in the Era of MRI-Targeted Prostate Biopsies.
    Urol Int. 2022;106:83-89.
    PubMed     Abstract available

  33. HAEUSER L, Reese SW, Paciotti M, Noldus J, et al
    Surgical Complications Requiring Intervention in Open versus Minimally Invasive Radical Prostatectomy.
    Urol Int. 2022;106:51-55.
    PubMed     Abstract available

  34. PFISTER D, Nestler T, Hartmann F, Haidl F, et al
    Feasibility and Oncologic Outcome of Salvage Surgery in Isolated Seminal Vesicle Remnants after Radical Prostatectomy.
    Urol Int. 2022;106:44-50.
    PubMed     Abstract available

  35. DING XF, Luan Y, Xia AL, Zhu LY, et al
    Application of 16 G Biopsy Needle in Transperineal Template-Guided Prostate Biopsy.
    Urol Int. 2022;106:909-913.
    PubMed     Abstract available

  36. SONG JA, He BM, Li HS, Yu XW, et al
    A Prospective Study Comparing Cancer Detection Rates of Transperineal Prostate Biopsies Performed by Junior Urologists versus a Senior Consultant in a Real-World Setting.
    Urol Int. 2022;106:884-890.
    PubMed     Abstract available

  37. KOZARIS R, Hanske J, von Landenberg N, Berg S, et al
    Psychosocial Distress in the Early Recovery Period after Radical Prostatectomy.
    Urol Int. 2022;106:891-896.
    PubMed     Abstract available

  38. ZHANG Z, Liang C
    Recurrent Prostatic Stromal Tumor of Uncertain Malignant Potential Combined with Concurrent Prostatic Adenocarcinoma: An Unusual Case.
    Urol Int. 2022;106:974-978.
    PubMed     Abstract available

    December 2021
  39. CROCEROSSA F, Carbonara U, Parekh J, Urdaneta A, et al
    PSA and PSA Kinetics as Predictors for 18F-Fluciclovine PET/CT Positivity in Biochemically Recurrent Prostate Cancer.
    Urol Int. 2021 Dec 21:1-8. doi: 10.1159/000520684.
    PubMed     Abstract available

  40. BERG S, Tully KH, von Landenberg N, Bahlburg H, et al
    How Many Cores Should Be Sampled during Systematic Prostate Biopsy in Case of Negative Multiparametric Magnetic Resonance Imaging? Analysis of 274 Men with Clinical Suspicion of Prostate Cancer.
    Urol Int. 2021 Dec 20:1-6. doi: 10.1159/000520598.
    PubMed     Abstract available

    November 2021
  41. FLEGAR L, Baunacke M, Buerk BT, Proschmann R, et al
    Decision Regret and Quality of Life after Focal Therapy with Vascular-Targeted Photodynamic Therapy (TOOKAD(R)) for Localized Prostate Cancer.
    Urol Int. 2021 Nov 23:1-6. doi: 10.1159/000520084.
    PubMed     Abstract available

  42. VESTRIS PG, Giwerc A, Hennequin C, Goujon A, et al
    Operative and Midterm Oncological Outcome of Focal Salvage Cryotherapy for Localized Prostate Cancer.
    Urol Int. 2021 Nov 15:1-6. doi: 10.1159/000518980.
    PubMed     Abstract available

    October 2021
  43. CETIN B, Wabl CA, Gumusay O
    Optimal Treatment for Patients with Oligometastatic Prostate Cancer.
    Urol Int. 2021 Oct 26:1-10. doi: 10.1159/000519386.
    PubMed     Abstract available

  44. GUO Y, Tian Y, Deng Y, Lu C, et al
    Diagnostic Performance of [18F]-Labeled PET/CT Tracers for Lymph Node/Bone Metastasis and Biochemical Recurrence Detection in Advanced Prostate Cancer: A Meta-Analysis.
    Urol Int. 2021 Oct 13:1-19. doi: 10.1159/000518478.
    PubMed     Abstract available

    September 2021
  45. LI Y, Cheng X, Zhu JL, Luo WW, et al
    Effect of Statins on the Risk of Different Stages of Prostate Cancer: A Meta-Analysis.
    Urol Int. 2021 Sep 8:1-9. doi: 10.1159/000518164.
    PubMed     Abstract available

    August 2021
  46. SONG P, Shu M, Yang L, Di X, et al
    The Prognosis of Radical Prostatectomy, External Beam Radiotherapy plus Brachytherapy, and External Beam Radiotherapy Alone for Patients above 70 Years with Very High-Risk Prostate Cancer: A Population-Matched Study.
    Urol Int. 2021 Aug 26:1-9. doi: 10.1159/000518113.
    PubMed     Abstract available

  47. PETERS R, Stephan C, Jung K, Lein M, et al
    Comparison of PHI and PHI Density for Prostate Cancer Detection in a Large Retrospective Caucasian Cohort.
    Urol Int. 2021 Aug 25:1-6. doi: 10.1159/000517891.
    PubMed     Abstract available

    July 2021
  48. TIAN B, Chunxiang E, Xiang Y, Teng P, et al
    Long Noncoding RNA LIPE-AS1 Drives Prostate Cancer Progression by Functioning as a Competing Endogenous RNA for microRNA-654-3p and Thereby Upregulating Hepatoma-Derived Growth Factor.
    Urol Int. 2021 Jul 7:1-16. doi: 10.1159/000516676.
    PubMed     Abstract available

    June 2021
  49. FERRO M, Terracciano D, Musi G, de Cobelli O, et al
    Increased Body Mass Index Is a Risk Factor for Poor Clinical Outcomes after Radical Prostatectomy in Men with International Society of Urological Pathology Grade Group 1 Prostate Cancer Diagnosed with Systematic Biopsies.
    Urol Int. 2021 Jun 24:1-8. doi: 10.1159/000516680.
    PubMed     Abstract available

    May 2021
  50. KOPP D, Kopp J, Bernhardt E, Manka L, et al
    68Ga-Prostate-Specific Membrane Antigen Positron Emission Tomography-Computed Tomography-Based Primary Staging and Histological Correlation after Extended Pelvic Lymph Node Dissection in Intermediate-Risk Prostate Cancer.
    Urol Int. 2021 May 7:1-7. doi: 10.1159/000515651.
    PubMed     Abstract available

  51. PORCARO AB, Siracusano S, Amigoni N, Tafuri A, et al
    The Influence of Endogenous Testosterone on Incidental Prostate Cancer after Transurethral Prostate Resection.
    Urol Int. 2021 May 7:1-9. doi: 10.1159/000514391.
    PubMed     Abstract available

  52. CELIK S, Kizilay F, Yorukoglu K, Aslan G, et al
    Sextant Biopsy-Based Criteria for Clinically Insignificant Prostate Cancer Are Also Valid for the 12-Core Prostate Biopsy Scheme: A Multicenter Study of Urooncology Association, Turkey.
    Urol Int. 2021 May 5:1-9. doi: 10.1159/000513658.
    PubMed     Abstract available

    January 2021
  53. MAURER V, Stahlberg J, Schiffmann I, Marks P, et al
    Continence and Complication Rates of Artificial Urinary Sphincter Devices (AMS 800) for Parkinson and Stroke Patients with Incontinence after Prostate Surgery: Retrospective Analysis of a Prospective Database.
    Urol Int. 2021;105.
    PubMed     Abstract available

  54. SHEN Q, Zhou Z, Liu Z, Hu S, et al
    Clinical and Pathological Features of Prostatic Stromal Tumor of Uncertain Malignant Potential: A Retrospective Study of 23 Chinese Cases.
    Urol Int. 2021;105.
    PubMed     Abstract available

  55. GOSSLER C, May M, Breyer J, Stojanoski G, et al
    High BMI, Aggressive Tumours and Long Console Time Are Independent Predictive Factors for Symptomatic Lymphocele Formation after Robot-Assisted Radical Prostatectomy and Pelvic Lymph Node Dissection.
    Urol Int. 2021;105.
    PubMed     Abstract available

  56. XU B, Ma BL, Peng YJ, Zhang Q, et al
    Learning Curve of an Innovative "3-Port" Laparoscopic Radical Prostatectomy: A Single-Center Analysis from 2016 to 2019.
    Urol Int. 2021;105.
    PubMed     Abstract available

  57. SCHMITZ-DRAGER BJ, Muhlich S, Lange C, Benderska-Soder N, et al
    Effectiveness and Distribution of Testosterone Levels within First Year of Androgen Deprivation Therapy in a Real-World Setting: Results from the Non-Interventional German Cohort LEAN Study.
    Urol Int. 2021;105.
    PubMed     Abstract available

  58. APFELBECK M, Schlenker B, Chaloupka M, Stief CG, et al
    Multiparametric MRI Lesion Classified as Prostate Imaging-Reporting and Data System 5 but Histopathologically Described as Benign: A Case Report and Review of Literature.
    Urol Int. 2021;105.
    PubMed     Abstract available

  59. NAKANISHI Y, Ito M, Kataoka M, Ikuta S, et al
    Who Can Avoid Biopsy of Magnetic Resonance Imaging-Negative Lobes without Compromising Significant Cancer Detection among Men with Unilateral Magnetic Resonance Imaging-Positive Lobes?
    Urol Int. 2021;105.
    PubMed     Abstract available

  60. PRATSINIS M, Babst C, Langenauer J, Schmid HP, et al
    Qualitative Assessment of Medical Information on YouTube: A Multilingual Comparison of Common Urological Conditions.
    Urol Int. 2021;105.
    PubMed     Abstract available

  61. MASSANOVA M, Robertson S, Barone B, Dutto L, et al
    The Comparison of Imaging and Clinical Methods to Estimate Prostate Volume: A Single-Centre Retrospective Study.
    Urol Int. 2021;105.
    PubMed     Abstract available

Thank you for your interest in scientific medicine.

AMEDEO Prostate Cancer is free of charge.